|
62
|
233
|
5lf4D |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
|
60
|
222
|
5l6bL |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with onx 0914 |
|
65
|
211
|
5l6aK |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
69
|
244
|
5l60B |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
53
|
204
|
5lf6I |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
|
58
|
195
|
5l67J |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924 |
|
66
|
200
|
5lf7K |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
|
58
|
195
|
5l63J |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
67
|
216
|
5lexM |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
|
67
|
250
|
5l63A |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
61
|
220
|
5lf1H |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
69
|
242
|
5l66D |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
|
76
|
231
|
5lm6A |
Vim-2 metallo-beta-lactamase in complex with 2-(3-fluoro-4-hydroxyphenyl)-3-oxoisoindoline-4-carboxylic acid (compound 35) |
|
70
|
243
|
5l6bF |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with onx 0914 |
|
67
|
233
|
5l64M |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
62
|
234
|
5lezE |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
|
63
|
231
|
5l5vE |
'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
64
|
239
|
5lf0F |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
57
|
195
|
5l62J |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
67
|
239
|
5lf1F |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
58
|
204
|
5l5sI |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
67
|
240
|
5l5vC |
'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
61
|
234
|
5leyE |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
|
70
|
240
|
5l62C |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
66
|
216
|
5lf3M |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
68
|
240
|
5l6aC |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
63
|
241
|
5l5yG |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
|
69
|
244
|
5l5vB |
'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
64
|
234
|
5lf0E |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
62
|
220
|
5lf3H |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
72
|
240
|
5l5xC |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
|
64
|
227
|
5lzp0 |
Binding of the c-terminal gqyl motif of the bacterial proteasome activator bpa to the 20s proteasome |
|
67
|
242
|
5l62D |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
65
|
216
|
5lezM |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
|
64
|
244
|
5lezG |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
|
67
|
213
|
5lezL |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
|
61
|
222
|
5l63L |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
66
|
237
|
5lf3C |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
61
|
196
|
5lttN |
Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924 |
|
67
|
233
|
5l6bM |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with onx 0914 |
|
65
|
233
|
5l5dM |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
|
55
|
204
|
5lf1I |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
66
|
239
|
5lf7F |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
|
58
|
204
|
5l6cI |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
63
|
211
|
5l5tK |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
68
|
233
|
5l6cM |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
60
|
222
|
5l62L |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
64
|
237
|
5lf1C |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
64
|
231
|
5l66E |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
|
67
|
250
|
5l6aA |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
